Corcept Therapeutics, Inc. (CORT)

80.22 -7.08 (-8.11%) USD  |  NASDAQ  |  Dec 16, 13:48
More

Corcept Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
United Therapeutics Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade